Circulating cardiac troponins levels and cardiac dysfunction in children with acute and fulminant viral myocarditis

Acta Paediatrica, International Journal of Paediatrics

Volumn 99, Issue 10, 2010, Pages 1510-1516

  Al Biltagi, Mohammed ^a   Issa, Mona ^b   Hagar, Hamdi Abo ^a   Abdel Hafez, Maher ^a   Aziz, Nahla Abdul ^a  

^a TANTA UNIVERSITY   (Egypt)

^b CAIRO UNIVERSITY   (Egypt)

Author keywords

Acute myocarditis; Cardiac troponin I; Cardiac troponin T; Children; Fulminant myocarditis

Indexed keywords

CORTICOSTEROID; DIURETIC AGENT; HYPERTENSIVE AGENT; IMMUNOGLOBULIN; IMMUNOMODULATING AGENT; INOTROPIC AGENT; TROPONIN; TROPONIN I; TROPONIN T; VASODILATOR AGENT;

ACUTE VIRAL MYOCARDITIS; ARTICLE; CHILD; CLINICAL ASSESSMENT; CONGESTIVE CARDIOMYOPATHY; CONTROLLED STUDY; DISEASE COURSE; DISEASE SEVERITY; FEMALE; FULMINANT VIRAL MYOCARDITIS; HEART FUNCTION; HEART LEFT VENTRICLE; HEART RIGHT VENTRICLE; HISTOPATHOLOGY; HUMAN; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RISK FACTOR; TISSUE DOPPLER IMAGING; TREATMENT OUTCOME; TWO DIMENSIONAL ECHOCARDIOGRAPHY; VIRUS MYOCARDITIS;

ACUTE DISEASE; CARDIOMYOPATHY, DILATED; FEMALE; HEART DISEASES; HUMANS; MALE; MYOCARDIAL CONTRACTION; MYOCARDITIS; TROPONIN I; TROPONIN T; ULTRASONOGRAPHY, DOPPLER;

EID: 77956385562     PISSN: 08035253     EISSN: 16512227     Source Type: Journal    
DOI: 10.1111/j.1651-2227.2010.01882.x     Document Type: Article

References (29)

1. Leonard EG. Viral myocarditis. Pediatr Infect Dis J 2004 23: 665 666.
2. Mecham N. Acute viral myocarditis in the ED pediatric patient: three case presentations. J Emerg Nurs 2004 30: 179 182.
3. Calabrese F, Rigo E, Milanesi O, Boffa GM, Angelini A, Valente M, et al. Molecular diagnosis of myocarditis and dilated cardiomyopathy in children: clinicopathologic features and prognostic implications. Diagn Mol Pathol 2002 11: 212 221.
4. Baboonian C, McKenna W. Eradication of viral myocarditis: is there hope? J Am Coll Cardiol 2003 42: 473 476.
5. Levi D, Alejos J. Diagnosis and treatment of pediatric viral myocarditis. Curr Opin Cardiol 2001 16: 77 83.
6. Biesiadecki BJ, Cong SM, Nosek TM, Jin JP. Troponin T Core Structure and the Regulatory NH2-Terminal Variable Region. Biochemistry 2007 46: 1368 1379.
7. Göser S, Andrassy M, Buss SJ, Leuschner F, Volz CH, Ottl R, et al. Cardiac Troponin I but Not Cardiac Troponin T Induces Severe Autoimmune Inflammation in the Myocardium. Circulation 2006 114: 1693 1702.
8. Jaffe A. Use of cardiac biomarkers for detection of myocarditis. In: Cooper LT editor. Myocarditis: from bench to bedside. Totowa, NJ: Humana Press Inc, 2002: 283 294.
9. Goldmann B, Christenson R, Hamm C, Meinertz T, Ohman E. Implications of troponin testing in clinical medicine. Curr Control Trials Cardiovasc Med 2001 2: 75 84.
10. Felker GM, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Baughman KL, et al. Echocardiographic findings in fulminant and acute myocarditis. J Am Coll Cardiol 2000 36: 227 232.
11. Goto T, Takase H, Toriyama T, Sugiura T, Sato K, Ueda R, et al. Circulating concentrations of cardiac proteins indicate the severity of congestive heart failure. Heart 2003 89: 1303 1307.
12. Yuan Z, Shioji K, Kishimoto C. Immunohistological analyses of myocardial infiltrating cells in various animal models of myocarditis. Exp Clin Cardiol 2003 8: 13 6.
13. Burian J, Buser P, Eriksson U. Myocarditis: the immunologist's view on pathogenesis and treatment. Swiss Med Wkly 2005 135: 359 364.
14. Jaffe AS, Babuin L, Apple FS. Biomarkers in acute cardiac disease. J Am Coll Cardiol 2006 48: 1 11.
15. Smith SC, Ladenson JH, Mason JW, Jaffe AS. Elevations of cardiac troponin I associated with myocarditis: experimental and clinical correlates. Circulation 1997 95: 163 168.
16. Bachmaier K, Mair J, Offner F, Pummerer C, Neu N. Serum cardiac troponin T and creatine kinase-MB elevations in murine autoimmune myocarditis. Circulation 1995 92: 1927 1932.
17. Lauer B, Niederau C, Kuhl U, Schannwell M, Pauschinger M, Strauer BE, et al. Cardiac troponin T in patients with clinically suspected myocarditis. J Am Coll Cardiol 1997 30: 1354 1359.
18. Greaves K, Oxford JS, Price CP, Clarke GH, Crake T. The prevalence of myocarditis and skeletal muscle injury during acute viral infection in adults: measurement of cardiac troponins I and T in 152 patients with acute influenza infection. Arch Intern Med 2003 163: 165 168.
19. Kang Y. Molecular and Cellular Mechanisms of Cardiotoxicity. Environ Health Perspect 2001 109: 27 34.
20. Labugger R, Simpson J, Quick M, Brown H, Collier C, Neverova I, et al. Strategy for Analysis of Cardiac Troponins in Biological Samples with a Combination of Affinity Chromatography and Mass Spectrometry. Clin Chem 2003 49: 873 879.
21. Mohler ER, Ryan T, Segar DS, Sawada SG, Sonel AF, Perkins L, et al. Clinical utility of troponin T levels and echocardiography in the emergency department. Am Heart J 1998 135: 253 260.
22. Giannitsis E, Müller-Bardorff M, Kurowski V, Weidtmann B, Wiegand U, Kampmann M, et al. Independent prognostic value of cardiac troponin T in patients with confirmed pulmonary embolism. Circulation 2000 102: 211 217.
23. Freixa X, Sionis A, Castel Á, Guasch E, Loma-Osorio P, Arzamendi D, et al. Low Troponin-I Levels on Admission Are Associated With Worse Prognosis in Patients With Fulminant Myocarditis. Transplant Proc 2009 41: 2234.
24. Li Y, Heuser J, Kosanke S, Hemric M, Cunningham M. Protection against Experimental Autoimmune Myocarditis Is Mediated by Interleukin-10-Producing T Cells that Are Controlled by Dendritic Cells. Am J Pathol 2005 167: 5 15.
25. McCarthy RE, Boehmer JP, Hruban RH, Hutchins GM, Kasper EK, Hare JM, et al. Long-term outcome of fulminant myocarditis as compared with acute (nonfulminant) myocarditis. N Engl J Med 2000 342: 690 695.
26. Gurkan F, Alkaya A, Ece A, Haspolat K, Bosnak M, Bilici M, et al. Cardiac troponin-I as a marker of myocardial dysfunction in children with septic shock. Swiss Med Wkly 2004 134: 593 596.
27. Fenton KE, Sable CA, Bell MJ, Patel KM, Berger JT. Increases in serum levels of troponin I are associated with cardiac dysfunction and disease severity in pediatric patients with septic shock. Pediatr Crit Care Med 2004 5: 533 538.
28. Mehta NJ, Khan IA, Gupta V, Jani K, Gowda RM, Smith PR. Cardiac troponin I predicts myocardial dysfunction and adverse outcome in septic shock. Int J Cardiol 2004 95: 13 7.
29. ver Elst KM, Spapen HD, Nguyen DN, Garbar C, Huyghens LP, Gorus FK. Cardiac troponins I and T are biological markers of left ventricular dysfunction in septic shock. Clin Chem 2000 46: 650 657.